Last reviewed · How we verify

NCT05768438

Mulligan Mobilizations and McKenzie Exercises Along With Neural Mobilizations in Cervical Spondylosis

Status unknown NA Last updated 14 March 2023
What this trial tests

NA trial testing Mulligan with upper limb movement in Spondylosis in 80 participants. Status unknown.

Timeline
5 December 2022
Primary endpoint
5 December 2023
5 January 2024

Quick facts

Lead sponsorDow University of Health Sciences
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment80
Start date5 December 2022
Primary completion5 December 2023
Estimated completion5 January 2024
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Dow University of Health Sciences

Who can join

Adults 40 to 60, any sex, with Spondylosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cervical pain is one of the common problem among general population. However, cervical spondylosis may cause unavoidable neck pain and range limitations due to wear and tear changes in the cervical spine. This condition can further lead to dysfunction and neuro musculoskeletal symptoms. Literature suggests the use of Mulligan therapy, McKenzie exercises and Neural mobilizations in spondylosis. According to author's knowledge there is limited evidence regarding effects of specific treatment approach.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Spondylosis

Currently open trials in the same condition.

Other Dow University of Health Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05768438.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing